Announcements Talk on ‘How Pharma Companies Fudge Data’ on 23rd September 2019 in Mumbai   |   ESIC Medical College and PGIMSR, Chennai present Wissendurst’19 on 20 September 2019 with networking partner Forum for Medical Ethics Society and FMES’s Institute of Health Sciences   |   Citizenship, Governance and Accountability in Health – Join the COPASAH Conclave of Global Health Accountability and Human Rights Advocates: October 15-18, 2019 New Delhi, India   |   Open Letter: Stop the war on Syria’s hospitals

Truth in research labelling

John H Noble Jr

DOI: 10.20529/IJME.2017.035


This report describes the background and context of a currently circulating petition to the US Congress that seeks amendment of Section 801 of the Public Health Services Act (42 U.S.C. 282) to close a loophole in existing law which makes possible post hoc adjustment of randomised controlled trial (RCT) results reported to the Food and Drug Administration that differ from those reported to and to medical journals. The report describes the petition’s rationale, underlying assumptions, and support for its proposed remedy in deontological, consequentialist, and casuist philosophical ethics theories. It addresses the several reservations of the World Association of Medical Editors (WAME) with citations of evidence for the petition’s assertions. The report suggests that some medical journals are not unknowing victims but rather complicit enablers of the post hoc adjusted RCT results that they publish. Its closing remarks dwell on the negative impact that embrace of a neoliberal, anti-regulatory philosophy of government will likely have on any regulatory reform to promote the integrity of biomedical science and the future of evidence-based medicine.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US